Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Macular Atrophy With Pseudodrusen (EMAP)”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07348588
What this trial is testing

Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

Who this might be right for
Retinitis Pigmentosa (RP)Extensive Macular Atrophy With Pseudodrusen (EMAP)
Centro de Pesquisa Rubens Siqueira 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07341919
What this trial is testing

Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

Who this might be right for
Extensive Macular Atrophy With Pseudodrusen (EMAP)Retinitis Pigmentosa (RP)
Rubens Camargo Siqueira 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation